What is Chardan Capital’s Estimate for ALUR FY2025 Earnings?

Allurion Technologies, Inc. (NYSE:ALUR) – Equities research analysts at Chardan Capital reduced their FY2025 earnings per share estimates for shares of Allurion Technologies in a research report issued on Wednesday, September 3rd. Chardan Capital analyst K. Nakae now anticipates that the company will post earnings per share of ($3.45) for the year, down from their prior estimate of ($2.08). The consensus estimate for Allurion Technologies’ current full-year earnings is ($9.96) per share. Chardan Capital also issued estimates for Allurion Technologies’ FY2026 earnings at ($2.06) EPS.

Allurion Technologies (NYSE:ALUR) last announced its quarterly earnings data on Tuesday, August 19th. The company reported ($0.57) EPS for the quarter, beating analysts’ consensus estimates of ($0.65) by $0.08. The company had revenue of $3.38 million for the quarter, compared to analyst estimates of $6.20 million.

A number of other brokerages also recently commented on ALUR. Zacks Research upgraded Allurion Technologies to a “hold” rating in a research report on Tuesday, August 12th. Wall Street Zen downgraded Allurion Technologies from a “hold” rating to a “strong sell” rating in a research report on Saturday, August 16th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.83.

Allurion Technologies Stock Performance

Shares of NYSE:ALUR opened at $2.17 on Monday. Allurion Technologies has a one year low of $1.98 and a one year high of $20.00. The stock has a fifty day moving average of $2.59 and a 200-day moving average of $2.64. The company has a market capitalization of $16.81 million, a PE ratio of -0.17 and a beta of -0.46.

Institutional Trading of Allurion Technologies

A hedge fund recently bought a new stake in Allurion Technologies stock. XTX Topco Ltd acquired a new position in shares of Allurion Technologies, Inc. (NYSE:ALUR) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 13,037 shares of the company’s stock, valued at approximately $42,000. XTX Topco Ltd owned approximately 0.27% of Allurion Technologies at the end of the most recent quarter. 21.39% of the stock is currently owned by institutional investors and hedge funds.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.